Grafted dopamine neurons: Morphology, neurochemistry, and electrophysiology

Progress in Neurobiology

Volumn 90, Issue 2, 2010, Pages 190-197

  Strömberg, Ingrid ^a   Bickford, Paula ^b   Gerhardt, Greg A ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b College of Medicine ^*  (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Dopamine; Electrophysiology; Neurochemistry; Parkinson's disease; Transplant

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; NORADRENALIN;

CAUDATE NUCLEUS; CELL GROWTH; CELL MEMBRANE DEPOLARIZATION; CELL SUBPOPULATION; CELL SURVIVAL; CLINICAL TRIAL; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTROCHEMISTRY; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; MESENCEPHALON; MONOAMINE NERVE CELL; NERVE FIBER GROWTH; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NERVOUS TISSUE; NEUROANATOMY; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REINNERVATION; REVIEW; SENSORY NERVE; SYMPTOM; TARGET CELL; TISSUE GRAFT; TISSUE TRANSPLANTATION;

ANIMALS; DOPAMINE; ELECTROPHYSIOLOGY; GRAFT SURVIVAL; HUMANS; NEUROCHEMISTRY; NEURONS; PARKINSON DISEASE; TRANSPLANTS;

EID: 76849083918     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.10.009     Document Type: Review

References (95)

1. Agnati L.F., Bjelke B., and Fuxe K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med. Res. Rev. 15 (1995) 33-45
2. Arbuthnott G., Dunnett S., and MacLeod N. Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain. Neurosci. Lett. 57 (1985) 205-210
3. Backlund E.-O., Granberg P.O., Hamberger B., Knutsson E., Mårtensson A., Sedvall G., Seiger A., and Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg. 62 (1985) 169-173
4. Bankiewicz K.S., Plunkett R.J., Jakobowitz D.M., Kopin I.J., and Oldfield E.H. Sprouting-induced recovery from MPTP-induced parkinsonism in primates after fetal non-dopaminergic brain implants; Histochemical and behavioral studies. J. Neurosurg. 74 (1991) 97-101
5. Berglöf E., and Strömberg I. Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study. Exp. Neurol. 216 (2009) 158-165
6. Bickford-Wimer P., Kim M., Boyajian C., Cooper D.M.F., and Freedman R. Effects of pertussis toxin on caudate neurons electrophysiology: studies with D1 and D2 agonists. Brain Res. 533 (1990) 263-267
7. Birkmayer W., and Hornykiewicz O. Der 1-3, 4-dioxyphenylalanin (l-DOPA)-effekt bei der Parkinson-akinesia. Klin. Wochenschr. 73 (1961) 787-788
8. Björklund A., and Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177 (1979) 555-560
9. Björklund L., Vidal N., and Strömberg I. Lazaroid-enhanced survival of grafted dopamine neurons does not increase target innervation. NeuroReport 9 (1998) 2815-2819
10. Björklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., and Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2344-2349
11. Bohn M.C., Cupit L., Marciano F., and Gash D.M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237 (1987) 913-916
12. Bolam J.P., Freund T.F., Björklund A., Dunnett S.B., and Smith A.D. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host striatum. Exp. Brain Res. 68 (1987) 131-146
13. Boyajian C., Bickford-Wimer P., Kim M., Cooper D.M.F., and Freedman R. Pertussus toxin lesioning of the nucleus caudate-putamen attenuates adenylate cyclase inhibition and alters neuronal eletrophysiological activity. Brain Res. 495 (1989) 66-74
14. Brundin P., Nilsson O., Strecker R., Lindvall O., Åstedt B., and Björklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65 (1986) 235-240
15. Brundin P., Strecker R., Widner H., Clarke D., Nilsson O., Åstedt B., Lindvall O., and Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70 (1988) 192-208
16. Clarke D., Brundin P., Strecker R., Nilsson O., Björklund A., and Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultratructural evidence for synapse formation using tyrosine hydroxylase immunoctyochemistry. Exp. Brain Res. 73 (1988) 115-126
17. Cotzias G., van Woert M., and Schiffert L. Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276 (1967) 374-379
18. Cragg S.J., Clarke D.J., and Greenfield S.A. Real-time dynamics of dopamine released from neuronal transplants in experimental Parkinson's disease. Exp. Neurol. 164 (2000) 145-153
19. Dahlström A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of the brain stem neurons. Acta Physiol. Scand. 62 Suppl. 232 (1964) 1-55
20. Date I., Felten S.Y., Olschowka J.A., and Felten D.A. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp. Neurol. 107 (1990) 197-207
21. Di Loreto S., Florio T., Capozzo A., Napolitano A., Adorno D., and Scarnati E. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Exp. Neurol. 138 (1996) 318-326
22. Fiandaca M.S., Kordower J.H., Hansen J.T., Jiao S.S., and Gash D.M. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 102 (1988) 76-91
23. Fisher L.J., Young S.J., Tepper J.M., Groves P.M., and Gage F.H. Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience 40 (1991) 109-122
24. Freed C., Greene P., Breeze R., Tsai W., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojansowski J., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (2001) 710-719
25. Freed W., Morihisa J., Spoor E., Hoffer B., Olson L., Seiger A., and Wyatt R. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 292 (1981) 351-352
26. Freed W.J., Cannon-Spoor H.E., and Krauthamer E. Intrastriatal adrenal medulla grafts in rats. Long-term survival and behavioral effects. J. Neurosurg. 65 (1986) 664-670
27. Freund T.F., Bolam J.P., Björklund A., Stenevi U., Dunnett S.B., Powell J.F., and Smith A.D. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5 (1985) 603-616
28. Gerfen C.R., Baimbridge K.G., and Miller J.J. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8780-8784
29. Gerfen C.R., Baimbridge K.G., and Thibault J. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 7 (1987) 3935-3944
30. Gerfen C.R., Herkenham M., and Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7 (1987) 3915-3034
31. Gerhardt G.A., Cass W.A., Hudson J., Henson M., Zhang Z., Ovadia A., Hoffer B.J., and Gash D.M. In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys. J. Neurochem. 66 (1996) 579-588
32. Gerhardt G.A., Oke A.F., Nagy G., Moghaddam B., and Adams R.N. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 190 (1984) 390-395
33. Gerhardt G.A., Palmer M.R., Seiger A., Adams R.N., Olson L., and Hoffer B.J. Adrenergic transmission in hippocampus-locus coeruleus double grafts in oculo: demonstration by in vivo electrochemical detection. Brain Res. 306 (1984) 316-325
34. Gerhardt G.A., Rose G., Strömberg I., Conboy G., Olson L., Jonsson G., and Hoffer B.J. Dopaminergic neurotoxicity of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 235 (1985) 259-265
35. Gould T.J., Strömberg I., and Bickford P.C. Decline in striatal dopamine D1 and D2 receptor activation in aged F344 rats. Neurobiol. Aging 17 (1996) 877-883
36. Hall M.E., Hoffer B.J., and Gerhardt G.A. Rapid and sensitive determination of catecholamines in small tissue samples by high-pressure liquid chromatograhy coupled with dual-electrode coulometric electrochemical detection. Liquid Chromatogr./Gas Chromatogr. (LCGC) 7 (1989) 258-265
37. Haque N.S.K., LeBlanc C.J., and Isacson O. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant. 6 (1997) 239-248
38. Herrera-Marschitz M., Strömberg I., Olsson D., Olson L., and Ungerstedt U. Adrenal medullary implants in the dopamine-denervated rat striatum. II. Rotational behavior during the first seven hours as a function of graft amount and location and its modulation by neuroleptics. Brain Res. 297 (1984) 53-61
39. Hudson J., Bickford P., Johansson M., Hoffer B.J., and Strömberg I. Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation. J. Neurosci. 14 (1994) 283-290
40. Hull C.D., Levine M.S., Buchwald N.A., Heller A., and Browning R.A. The spontaneous firing pattern of forebrain neurons. I. The effects of dopamine and non-dopamine depleting lesions on caudate unit firing patterns. Brain Res. 73 (1974) 241-262
41. Itakura T., Kamei I., Nakai K., Naka Y., Nakakita K., Imai H., and Komai N. Autotransplantation of the superior cervial ganglion into the brain. J. Neurosurg. 68 (1988) 955-959
42. Jaeger C.B. Cytoarchitectonics of substantia nigra grafts: a light- and electronmicroscopic study of immunocytochemically identified dopaminergic neurons and fibrous astrocytes. J. Comp. Neurol. 231 (1985) 121-135
43. Jaumotte J.D., and Zigmond M.J. Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF. Mol. Brain Res. 134 (2005) 139-146
44. Jimenez-Castellanos J., and Graybiel A.M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23 (1987) 223-242
45. Johansson S., and Strömberg I. Fetal lateral ganglionic eminence attracts one of two morphologically different types of tyrosine hydroxylase-positive nerve fibers formed by cultured ventral mesencephalon. Cell Transplant. 12 (2003) 243-255
46. Kamo H., Kim S., McGeer P., and Shin D. Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons. Brain Res. 397 (1986) 372-376
47. Kordower J.H., Goetz C.G., Freeman T.B., and Olanow C.W. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp. Neurol. 144 (1997) 41-46
48. Lindvall O., and Björklund A. Dopaminergic innervation of the glubus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172 (1979) 169-173
49. Lindvall O., Rehncrona S., Brundin P., Gustavii B., Åstedt B., Widner H., Lindholm T., Björklund A., Leenders K.L., Rothwell J.C., Frackowiak R., Marsden C.D., Johnels B., Steg G., Freedman R., Hoffer B.J., Seiger A., Bygdeman M., Strömberg I., and Olson L. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46 (1989) 615-631
50. Mahalik T.J., Finger T.E., Strömberg I., and Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J. Comp. Neurol. 260 (1985) 60-70
51. McCaffery P., and Drager U.C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7772-7776
52. Muramatsu S.I., Okuno T., Suzuki Y., Nakayama T., Kakiuchi T., Takino N., Iida A., Ono F., Terao K., Inoue N., Nakano I., Kondo Y., and Tsukada H. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse 63 (2009) 541-548
53. Nakai M., Itakura T., Kamei I., Nakai K., Naka Y., Imai H., and Komai N. Auotologous transplantation of the superior cervical ganglion into the brain of parkinsonian monkeys. J. Neurosurg. 72 (1990) 1-95
54. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., and Björklund A. A microtransplantation approach for cell suspension grafting in the rat parkinson model: a detailed account of the methodology. Neuroscience 63 (1994) 57-72
55. Olanow C., Goetz C., Kordower J., Stoessl A., Sossi V., Brinn M., Shannon K., Nauert G., Perl D., Godbold J., and Freeman T. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 (2003) 403-414
56. Olson L., Seiger A., and Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res. 44 (1972) 283-288
57. Parish C.L., Castelo-Branco G., Rawal N., Tonnesen J., Sorensen A.T., Salto C., Kokaia M., Lindvall O., and Arenas E. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J. Clin. Invest. 118 (2008) 149-160
58. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. fourth ed. (1998), Academic Press, New York
59. Perlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., and Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204 (1979) 643-647
60. Rice M.E., and Cragg S.J. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res. Rev. 58 (2008) 303-313
61. Rodriguez-Gomez J.A., Lu J.Q., Velasco I., Rivera S., Zoghbi S.S., Liow J.S., Musachio J.L., Chin F.T., Toyama H., Seidel J., Green M.V., Thanos P.K., Ichise M., Pike V.W., Innis R.B., and McKay R.D. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25 (2007) 918-928
62. Rose G., Gerhardt G., Strömberg I., Olson L., and Hoffer B. Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: an in vivo electrochemical study. Brain Res. 341 (1985) 92-100
63. Rothblat D.S., and Schneider J.S. Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study. J. Neurochem. 72 (1999) 724-733
64. Schein J., Hunter D., and Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204 (1998) 432-450
65. Schueler S.B., Ortega J.D., Sagen J., and Kordower J.H. Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J. Neurosci. 13 (1993) 4496-4510
66. Schultzberg M., Dunnett S.B., Björklund A., Stenevi U., Hökfelt T., Dockray G.J., and Goldstein M. Dopamine and cholecystokinin immunoreactive neurons in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience 12 (1984) 17-32
67. Seroogy K.B., Dangaran K., Lim S., Haycock J.W., and Fallon J.H. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. J. Comp. Neurol. 279 (1989) 397-414
68. Siggins G., Hoffer B., and Ungerstedt U. Electrophysiological evidence for the involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons. Life Sci. 15 (1974) 779-792
69. Sladek Jr. J.R., Bjugstad K.B., Collier T.J., Bundock E.A., Blanchard B.C., Elsworth J.D., Roth R.H., and Redmond Jr. D.E. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate. Cell Transplant. 17 (2008) 427-444
70. Sortwell C.E., Collier T.J., and Sladek Jr. J.R. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons. J. Comp. Neurol. 399 (1998) 530-540
71. Steece-Collier K., Collier T.J., Danielson P.D., Kurlan R., Yurek D.M., and Sladek J.R.J. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov. Dis. 18 (2003) 1442-1454
72. Strecker R.E., Sharp T., Brundin P., Zetterström T., Ungerstedt U., and Björklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 22 (1987) 169-178
73. Strömberg I., Almqvist P., Bygdeman M., Finger T., Gerhardt G., Granholm A.-C., Mahalik T., Seiger A., Hoffer B., and Olson L. Intracerebral xenografts of human mesencephalic tissue into athymic rats: histochemical and in vivo electrochemical studies. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 8331-8434
74. Strömberg I., Almqvist P., Bygdeman M., Finger T., Gerhardt G., Granholm A.-C., Mahalik T., Seiger A., Olson L., and Hoffer B. Human fetal mesencephalic tissues grafted to dopamine-denervated striatum of athymic rats: light- and electron-microscopical histochemistry and in vivo chronoamperometric studies. J. Neurosci. 9 (1989) 614-624
75. Strömberg I., and Bickford P. Reduced aging effects of striatal neuronal discharge rate by aged ventral mesencephalic grafts. NeuroReport 7 (1996) 693-696
76. 2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions. Brain Res. 564 (1991) 279-285
77. Strömberg I., Björklund L., and Förander P. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study. Cell Transplant. 6 (1997) 287-296
78. Strömberg I., Bygdeman M., and Almqvist P. Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats. J. Comp. Neurol. 315 (1992) 445-456
79. Strömberg I., Bygdeman M., Goldstein M., Seiger A., and Olson L. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation. Neurosci. Lett. 71 (1986) 271-276
80. Strömberg I., Gemma C., Vila M., and Bickford P.C. Blueberry- and spirulina-enriched diets enhance striatal dopamine regeneration and induce a rapid, transient microglia activation after injury of the nigrostriatal dopamine system. Exp. Neurol. 196 (2005) 298-307
81. Strömberg I., Herrera-Marschitz M., Hultgren L., Ungerstedt U., and Olson L. Adrenal medullary implants in the dopamine-denervated rat striatum. I. Acute catecholamine levels in grafts and host caudate as determined by HPLC-electrochemistry and fluorescence histochemical image analysis. Brain Res. 297 (1984) 41-51
82. Strömberg I., Herrera-Marschitz M., Ungerstedt U., Ebendal T., and Olson L. Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res. 60 (1985) 335-349
83. Strömberg I., and Johansson M. Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts. Exp. Brain Res. 101 (1994) 73-85
84. Strömberg I., Johnson S., Hoffer B., and Olson L. Reinnervation of dopamine-denervated striatum by substantia nigra transplants. Immunocytochemical and electrophysiological correlates. Neuroscience 14 (1985) 981-998
85. Strömberg I., Kehr J., Andbjer B., and Fuxe K. Fetal ventral mecencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Exp. Neurol. 164 (2000) 154-165
86. Strömberg I., Törnqvist N., Johansson S., Bygdeman M., and Almqvist P. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons. Microsc. Res. Tech. 54 (2001) 287-297
87. Strömberg I., van Horne C., Bygdeman M., Weiner N., and Gerhardt G. Function of intraventricular human mesencephalic xenograft in immunosuppressed rats: an electrophysiological and neurochemical analysis. Exp. Neurol. 112 (1991) 140-152
88. Sydow O., Hansson P., Young D., Meyerson B., Backlund E.-O., Ebendal T., Farnebo L.O., Freedman R., Hamberger B., Hoffer B., Seiger A., Strömberg I., and Olson L. Long-term beneficial effects of adrenal medullary autografts supported by nerve growth factor in Parkinson's disease. Eur. J. Neurol. 2 (1995) 445-454
89. Thompson L., Barraud P., Andersson E., Kirik D., and Bjorklund A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25 (2005) 6467-6477
90. Törnqvist N., Björklund L., Almqvist P., Wahlberg L., and Strömberg I. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp. Neurol. 164 (2000) 130-138
91. Törnqvist N., Björklund L., and Strömberg I. Evidence for target-specific outgrowth from subpopulations of grafted dopaminergic neurons. A retrograde study using in oculo and intracranial grafting. Exp. Neurol. 169 (2001) 329-339
92. van Horne C., Hoffer B.J., Strömberg I., and Gerhardt G.A. Clearence and diffusion of locally applied dopamine in normal and 6-hydroxydoamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263 (1992) 1285-1292
93. Wictorin K., Brundin P., Sauer H., Lindvall O., and Björklund A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 323 (1992) 475-494
94. Zetterström T., Brundin P., Gage F.G., Sharper T., Isacson O., Dunnett S.B., Ungerstedt U., and Björklund A. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res. 362 (1986) 344-349
95. Zhou F.C., Chiang Y.H., and Wang Y. Constructing a new nigrostriatal pathway in the parkinsonian model with bridged neural transplantation in substantia nigra. J. Neurosci. 16 (1996) 6965-6974